Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.08
|
2.10
|
2.06
|
2.01
|
2.12
|
2.10
|
|
|
747 670.00
|
|
2.05
|
2.06
|
2.11
|
2.05
|
2.11
|
2.06
|
|
|
122 770.00
|
|
2.11
|
2.12
|
2.20
|
2.11
|
2.20
|
2.11
|
|
|
48 560.00
|
|
2.10
|
2.15
|
2.06
|
1.96
|
2.16
|
2.15
|
|
|
97 120.00
|
|
2.00
|
2.02
|
1.97
|
1.97
|
2.02
|
2.02
|
|
|
95 680.00
|
|
1.89
|
1.95
|
1.90
|
1.79
|
2.00
|
1.95
|
|
|
96 250.00
|
|
1.85
|
1.86
|
1.83
|
1.82
|
1.94
|
1.86
|
|
|
231 140.00
|
|
1.85
|
1.95
|
1.81
|
1.80
|
1.93
|
1.92
|
|
|
47 890.00
|
|
1.86
|
1.90
|
1.91
|
1.80
|
1.91
|
1.86
|
|
|
95 620.00
|
|
1.89
|
1.90
|
1.91
|
1.88
|
1.91
|
1.90
|
|
|
142 240.00
|
|
hanghai Bio-Heart Biological Technology Co Ltd is a China-based company mainly engaged in interventional instruments. The Company's main businesses are the development and production of interventional cardiovascular devices. The Company's main products include fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The Company's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension.